🚨 New PH Tweetorial Series is live! 🚨
Kicking off the new year with PH diagnosis—featuring 📻 a podcast, 💊 a challenging case discussion, and 📄 a must-read paper.
open.spotify.com/episode/1NHe...
site.thoracic.org/assemblies/p...
PMID: 30880632
@atsearlycareer.bsky.social @pvrinstitute.bsky.social
Not how I wanted to start the new year with grant writing. SciENcv fails for the day.
AHA Scientific Sessions 2026 #AHA26 will take place November 6-9, 2026, in Chicago 💨
Want to contribute to next year’s program? Submit your session ideas for #AHA26 by tomorrow January 6
Would especially love to hear from the vascular biology community
Link here:
forms.office.com/pages/respon...
⚠️ New Practical PH drop!! Continuing our Foundations in PH series, Dr. Kathryn del Valle and Dr. Raymond Benza have a discussion about risk stratification in PH. Available now on Apple Podcasts, YouTube and Spotify 🫁🫀
open.spotify.com/episode/0H2V...
Excited for #AHA25 to start. The ever popular 3CPR Speed Mentoring session is happening this afternoon. Later there is both an early career networking event and the 3CPR & #ReSS welcome reception. A jammed packed afternoon.
Here are some helpful PC-links with our latest activity:
🛜🔗
What's New: site.thoracic.org/assemblies/p....
PC Webinars: site.thoracic.org/assemblies/p...
Practical PH Podcasts: site.thoracic.org/assemblies/p...
The New England Journal of Medicine Sotatercept for Pulmonary Arterial Hypertension within the First Year A Research Summary based on McLaughlin VV et al. | 10.1056/NEJMoa2508170 | Published on September 30, 2025 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.
Among adults with pulmonary arterial hypertension who had received the diagnosis less than 1 year earlier, the addition of sotatercept to background therapy resulted in a lower risk of clinical worsening than placebo. Full HYPERION phase 3 trial results and Research Summary: nej.md/4mzuaY1
🚨 New trial alert: HYPERION🚨
Troy Stevens, PhD presenting the Terry Wagner Memorial Lecture: Impact of Age on Endothelial Heterogeneity in the Pulmonary Vasculature
@ats-pc.bsky.social #groverconference2025
🚨 We have 2-3 post-doc openings and an opening for a lab manager, all in soft material/tissue mechanics. 🚨
Check out www.manuelrausch.com and submit an application here: lnkd.in/e7W27XwZ. Please share with interested parties and your network. Many thanks ❤️!
Happy Monday! Let's start the week right with an early career highlight 🥁 Introducing Dr. Forbes:
The Blue Journal thanks Alexander M. K. Rothman, BMBCh, MRCP, PhD, for his contribution to the June issue
Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study
@atscommunity.bsky.social #PAH
🔓Open Access
www.atsjournals.org/doi/full/10....
📢 Get ready to submit your abstract to PVRI 2026 Dublin — registrations & the abstract portal will open on 1 July! Stay tuned for full details on how to register and submit your abstract! pvrinstitute.org/pvri2026
#PVRI2026 #PulmonaryHypertension #GlobalScience #Congress
Hot off the press 🔥: Check out this guideline summary on interventional strategies for children with progressive pulmonary hypertension in the June issue of Annals ATS. www.atsjournals.org/doi/full/10....
⏰ Submit your proposals for ATS 2026 in Orlando!
📅 Call for input is open now through June 25. Learn more in ATS Conference News: www.atsconferencenews.org/ats-2026-int...
Missing all the networking at ATS 2025? Here is a PC Assembly early career highlight! Meet Dr. Shen:
Please join our latest discussions: tle: “3D Imaging Reveals Complex Microvascular Remodeling in the Right Ventricle in
Pulmonary Hypertension”
Date/Time: Tues, June. 3, 2025, 12 p.m. eastern
Registration Link:
thoracic.zoom.us/meeting/regi...
Presenter: Edda Spiekerkoetter, MD
Happening this Tuesday!
🩺 Join us for the @ats-pc.bsky.social journal club next week!
📅 Tue, June 3, 2025, 12pm ET
🎤 Presenter: Dr. Edda Spiekerkoetter, MD
Register Now! thoracic.zoom.us/meeting/regi...
Excellent job covering #ATS2025. Thanks for your hard work!
The PHun doesn’t stop there! Head over to the Poster Discussion on Late-Breaking Abstracts in 3009/3011 or Mini Symposium on Novel Models of Metabolism and Vascular Remodeling in 2009/2011. 👟👟
PC has saved some of the best sessions for last at #ATS2025
⏰Wednesday May 21 starting at 8:15 AM PST - all in Moscone West so you don't have to miss out on anything!🙌
This afternoon’s #ATS2025 session has been wonderful! Our own #CoreyVentetuolo spoke about lessons we’ve learned about EC plasticity from our cell biopsy method. @brownmedicine.bsky.social @ats-pc.bsky.social
Let’s update “low risk” in #PAH! Awesome presentation from
@SandeepSahayMD
& team: “A Refined Definition of Low Risk in Patients with PAH: Incorporating Mortality and Morbidity”
Big things happening this morning in B26 - Oracle Park 👁️👁️ come check it out!
Kicking things off with very encouraging data looking at survival with PAH using analyses from STELLAR and SOTERIA trials!
Don’t forget this one!! Navigating Mid Career challenges from PAH luminaries.
Good Morning and welcome to another awesome day at #ATS2025! Today is jam-packed with 🔥#PVD #PH #RV #PulmCirc sessions, so put those 👟on & get excited for all these great presentations 🎉 And don’t miss our
@ats-pc.bsky.social
meeting TODAY at 5p! Today’s sessions ⬇️
Looking to the PH-uture 👀: Mapping the Chemical Shift of 20Xenon in the Red Blood Cells as a Biomarker for PH. #DrBastianDriehuys
Patient insurance type matters in #PAH! Wonderful presentation from #DrBreanneMcCarthy: “Impact of Insurance Type in Treatment Patterns in PAH: The Pulmonary Hypertension Association Registry” @atsearlycareer.bsky.social #PennMedPH
